Literature DB >> 3396603

Thrombo-embolic complications after splenectomy in HbE-beta-thalassaemia.

F A Wijburg, W van den Berg, A van Teunenbroek, R S Weening.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396603     DOI: 10.1007/bf00496435

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  5 in total

1.  Decreased erythrocyte survival in hemoglobin H disease as a result of the abnormal properties of hemoglobin H: the benefit of splenectomy.

Authors:  D A RIGAS; R D KOLER
Journal:  Blood       Date:  1961-07       Impact factor: 22.113

2.  Differentiation of certain platelet factors related to blood coagulation.

Authors:  E DEUTSCH; S A JOHNSON; W H SEEGERS
Journal:  Circ Res       Date:  1955-01       Impact factor: 17.367

3.  Persistent post-splenectomy thrombocytosis and thrombo-embolism: a consequence of continuing anaemia.

Authors:  J Hirsh; J V Dacie
Journal:  Br J Haematol       Date:  1966-01       Impact factor: 6.998

4.  Splenic sequestration and ineffective erythropoiesis in hemoglobin E-beta-thalassemia disease.

Authors:  F B Ruymann; L A Popejoy; R B Brouillard
Journal:  Pediatr Res       Date:  1978-10       Impact factor: 3.756

5.  Interaction of antithrombin III with bovine aortic segments. Role of heparin in binding and enhanced anticoagulant activity.

Authors:  D Stern; P Nawroth; J Marcum; D Handley; W Kisiel; R Rosenberg; K Stern
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

  5 in total
  2 in total

Review 1.  Vascular complications after splenectomy for hematologic disorders.

Authors:  Shelley E Crary; George R Buchanan
Journal:  Blood       Date:  2009-07-27       Impact factor: 22.113

2.  Transdermal estradiol substitution therapy for the induction of puberty in female hypogonadism.

Authors:  M Cisternino; K Nahoul; M Bozzola; G Grignani; G Perani; P Sampaolo; M Roger; F Severi
Journal:  J Endocrinol Invest       Date:  1991-06       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.